Pillar I · Standardized Industry Report
Diagnostics & Labs — KSA Industry Report
Diagnostics & LabsCare DeliveryISIC 8690↑ Growth
◐ Analyst-reviewedContains modeled estimatesVintage: Q2 2026Refresh: semiannual
01
Summary
Seed report — all figures are Noura modeled estimates pending sourced data.
Diagnostics is scaling on chain consolidation and preventive-care expansion.
02
Market size
Market size (actual/latest)Forecast
Diagnostics & lab market
SAR 11,000 mn2024Modeled estimateMethod: Order-of-magnitude modeled placeholder.03
Five-year forecast
Projected market size
SAR 17,000 mn2029Modeled estimateMethod: 5-yr projection; placeholder.Forecast CAGR (2024–2029)
9%2024–2029Modeled estimateMethod: Modeled placeholder.Forecast assumptions
- · Preventive-screening programs and chronic-disease management expand test volumes.
04
Segmentation
Clinical laboratory70%Modeled estimate
Imaging diagnostics30%Modeled estimate
05
Drivers & constraints
Drivers
- ↑Preventive-care push
National screening programs raise routine testing.
- ↑Chain consolidation
Scale lab networks gain pricing and logistics advantage.
Constraints
- Reimbursement pressure
Per-test tariffs limit margin expansion.
06
Competitive landscape
Market structure
Consolidating around national chains2024Modeled estimateMethod: Qualitative modeled read.National lab chains lead; hospital labs serve captive volumes.
07
Key players
Al Borg DiagnosticsAl Mokhtabarnational lab chains (market operators)
08
Outlook
↑ Growth
Steady volume-led growth; consolidation is the value-creation lever.
Regulatory factors
Ministry of Health (MOH)Saudi Food & Drug Authority (SFDA)Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI)
09
Sources & methodology
Trust ladder on this report:SourcedTriangulatedModeled estimate
- [1]Noura modeled estimate — see Methodology
Figures tagged as modeled estimates are not sourced facts. Each shows the method used to derive it. See the full methodology page. Methodology →